住友ファーマの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2022/02/14 | 1,256 | 1,268 | 1,243 | 1,245 | -17 | -1.3% | 1,237,600 |
2022/02/10 | 1,266 | 1,272 | 1,255 | 1,262 | +10 | +0.8% | 1,307,900 |
2022/02/09 | 1,253 | 1,259 | 1,232 | 1,252 | +5 | +0.4% | 1,264,700 |
2022/02/08 | 1,218 | 1,254 | 1,218 | 1,247 | +5 | +0.4% | 991,600 |
2022/02/07 | 1,235 | 1,248 | 1,223 | 1,242 | +4 | +0.3% | 940,100 |
2022/02/04 | 1,225 | 1,241 | 1,210 | 1,238 | -13 | -1% | 1,192,800 |
2022/02/03 | 1,221 | 1,254 | 1,216 | 1,251 | +18 | +1.5% | 1,425,500 |
2022/02/02 | 1,190 | 1,242 | 1,182 | 1,233 | +58 | +4.9% | 2,153,400 |
2022/02/01 | 1,183 | 1,205 | 1,174 | 1,175 | -71 | -5.7% | 2,748,700 |
2022/01/31 | 1,247 | 1,259 | 1,229 | 1,246 | -14 | -1.1% | 1,542,500 |
2022/01/28 | 1,248 | 1,275 | 1,240 | 1,260 | -16 | -1.3% | 1,418,100 |
2022/01/27 | 1,310 | 1,311 | 1,265 | 1,276 | -38 | -2.9% | 1,520,800 |
2022/01/26 | 1,349 | 1,360 | 1,314 | 1,314 | -35 | -2.6% | 925,900 |
2022/01/25 | 1,327 | 1,352 | 1,311 | 1,349 | +11 | +0.8% | 1,193,200 |
2022/01/24 | 1,327 | 1,338 | 1,313 | 1,338 | +14 | +1.1% | 764,200 |
2022/01/21 | 1,317 | 1,327 | 1,304 | 1,324 | -22 | -1.6% | 829,400 |
2022/01/20 | 1,336 | 1,361 | 1,327 | 1,346 | +8 | +0.6% | 798,800 |
2022/01/19 | 1,338 | 1,356 | 1,331 | 1,338 | -36 | -2.6% | 1,018,600 |
2022/01/18 | 1,381 | 1,392 | 1,368 | 1,374 | -7 | -0.5% | 629,000 |
2022/01/17 | 1,379 | 1,398 | 1,372 | 1,381 | +11 | +0.8% | 507,900 |
2022/01/14 | 1,386 | 1,399 | 1,356 | 1,370 | -37 | -2.6% | 1,184,900 |
2022/01/13 | 1,419 | 1,420 | 1,391 | 1,407 | +18 | +1.3% | 1,444,600 |
2022/01/12 | 1,369 | 1,395 | 1,368 | 1,389 | +34 | +2.5% | 1,081,400 |
2022/01/11 | 1,343 | 1,357 | 1,342 | 1,355 | +12 | +0.9% | 789,000 |
2022/01/07 | 1,345 | 1,363 | 1,336 | 1,343 | +15 | +1.1% | 1,126,900 |
2022/01/06 | 1,360 | 1,367 | 1,328 | 1,328 | -32 | -2.4% | 1,263,200 |
2022/01/05 | 1,347 | 1,367 | 1,346 | 1,360 | -6 | -0.4% | 980,500 |
2022/01/04 | 1,342 | 1,366 | 1,330 | 1,366 | +41 | +3.1% | 882,100 |
2021/12/30 | 1,341 | 1,344 | 1,321 | 1,325 | -23 | -1.7% | 863,000 |
2021/12/29 | 1,339 | 1,357 | 1,339 | 1,348 | -9 | -0.7% | 635,900 |
2021/12/28 | 1,354 | 1,363 | 1,350 | 1,357 | -3 | -0.2% | 581,900 |
2021/12/27 | 1,373 | 1,376 | 1,354 | 1,360 | -13 | -0.9% | 389,700 |
2021/12/24 | 1,388 | 1,389 | 1,362 | 1,373 | -9 | -0.7% | 360,900 |
2021/12/23 | 1,386 | 1,391 | 1,374 | 1,382 | -3 | -0.2% | 428,400 |
2021/12/22 | 1,378 | 1,397 | 1,371 | 1,385 | +7 | +0.5% | 512,300 |
2021/12/21 | 1,358 | 1,383 | 1,352 | 1,378 | +43 | +3.2% | 934,000 |
2021/12/20 | 1,307 | 1,337 | 1,306 | 1,335 | +4 | +0.3% | 889,500 |
2021/12/17 | 1,346 | 1,358 | 1,327 | 1,331 | -24 | -1.8% | 842,200 |
2021/12/16 | 1,353 | 1,358 | 1,341 | 1,355 | +23 | +1.7% | 659,300 |
2021/12/15 | 1,329 | 1,338 | 1,321 | 1,332 | +4 | +0.3% | 835,400 |
2021/12/14 | 1,316 | 1,340 | 1,316 | 1,328 | +9 | +0.7% | 748,300 |
2021/12/13 | 1,359 | 1,359 | 1,316 | 1,319 | -17 | -1.3% | 893,700 |
2021/12/10 | 1,346 | 1,353 | 1,329 | 1,336 | -32 | -2.3% | 1,664,600 |
2021/12/09 | 1,390 | 1,399 | 1,361 | 1,368 | -22 | -1.6% | 918,700 |
2021/12/08 | 1,382 | 1,396 | 1,367 | 1,390 | +9 | +0.7% | 1,179,800 |
2021/12/07 | 1,337 | 1,386 | 1,337 | 1,381 | +56 | +4.2% | 1,932,800 |
2021/12/06 | 1,326 | 1,355 | 1,322 | 1,325 | -31 | -2.3% | 1,500,500 |
2021/12/03 | 1,357 | 1,371 | 1,337 | 1,356 | +8 | +0.6% | 1,399,400 |
2021/12/02 | 1,358 | 1,375 | 1,347 | 1,348 | -31 | -2.2% | 1,486,100 |
2021/12/01 | 1,374 | 1,392 | 1,363 | 1,379 | -3 | -0.2% | 1,728,400 |
801~
850
件表示中 / 3705件
類似銘柄と比較する
現在ご覧いただいている「住友ファーマ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
住友ファーマ | 78,300円 | -11.0% | +206.6% | 0.00% | 7.78倍 | 1.84倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
ロート | 204,000円 | +8.4% | +0.2% | 2.06% | 14.83倍 | 1.78倍 |
|
一般用医薬品の目薬で世界首位。「肌研」が急成長しスキンケアが柱に。アジアなど海外積極進出 |
久光薬 | 415,400円 | +5.8% | +1.2% | 2.89% | 13.78倍 | 1.10倍 |
|
貼る鎮痛消炎剤首位。医療用シェア5割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
ツムラ | 349,600円 | +3.8% | -19.9% | 3.89% | 11.44倍 | 0.88倍 |
|
医療用漢方薬で国内シェア8割超。高齢者、がん支持療法、女性関連の3領域を重点に市場深耕 |
日本新薬 | 345,300円 | +8.0% | -15.3% | 3.59% | 9.69倍 | 0.94倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
市場注目の銘柄
チャート関連のコラム